loading
Schlusskurs vom Vortag:
$1.75
Offen:
$1.75
24-Stunden-Volumen:
191.91K
Relative Volume:
0.13
Marktkapitalisierung:
$141.07M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.29%
1M Leistung:
-9.14%
6M Leistung:
+50.42%
1J Leistung:
-4.28%
1-Tages-Spanne:
Value
$1.74
$1.83
1-Wochen-Bereich:
Value
$1.57
$1.83
52-Wochen-Spanne:
Value
$0.5506
$6.19

Citius Oncology Inc Stock (CTOR) Company Profile

Name
Firmenname
Citius Oncology Inc
Name
Telefon
(908) 967-6677
Name
Adresse
11 COMMERCE DRIVE, CRANFORD
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
CTOR's Discussions on Twitter

Vergleichen Sie CTOR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
CTOR
Citius Oncology Inc
1.80 137.15M 0 0 0 0.00
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
155.42 67.51B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.14 47.88B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.6942 43.42B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.27 20.72B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
307.31 14.21B 2.99B 1.21B 1.13B 25.06

Citius Oncology Inc Stock (CTOR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-27 Eingeleitet Maxim Group Buy

Citius Oncology Inc Aktie (CTOR) Neueste Nachrichten

pulisher
Aug 20, 2025

Citius Oncology Conducts Public Offering of Stock - MSN

Aug 20, 2025
pulisher
Aug 19, 2025

Citius Oncology Announces Closing of $9.0 Million Public Offering - ADVFN Brasil

Aug 19, 2025
pulisher
Aug 18, 2025

Citius Oncology files prospectus supplement to update S-1 registration By Investing.com - Investing.com Australia

Aug 18, 2025
pulisher
Aug 18, 2025

Citius Oncology files prospectus supplement to update S-1 registration - Investing.com

Aug 18, 2025
pulisher
Aug 18, 2025

RSI Suggests Rebound May Be Near in Citius Oncology Inc.M&A Rumor & AI Driven Stock Movement Reports - classian.co.kr

Aug 18, 2025
pulisher
Aug 18, 2025

Trading Bots Trigger Alerts on Citius Oncology Inc. ActivityGold Moves & Daily Momentum Trading Reports - classian.co.kr

Aug 18, 2025
pulisher
Aug 18, 2025

Citius Oncology Inc. Added to High Probability Setup ListWall Street Watch & Free Real-Time Volume Trigger Notifications - newsimpact.co.kr

Aug 18, 2025
pulisher
Aug 18, 2025

Will Citius Oncology Inc. Benefit From Broader Market BounceJuly 2025 Review & Entry and Exit Point Strategies - classian.co.kr

Aug 18, 2025
pulisher
Aug 17, 2025

Published on: 2025-08-17 14:00:03 - mustnews.co.kr

Aug 17, 2025
pulisher
Aug 16, 2025

Is Citius Oncology Inc. exposed to currency risks2025 Volume Leaders & Reliable Momentum Entry Alerts - sundaytimes.kr

Aug 16, 2025
pulisher
Aug 16, 2025

Is Citius Oncology Inc. showing insider buyingWeekly Investment Summary & Fast Entry Momentum Trade Alerts - thegnnews.com

Aug 16, 2025
pulisher
Aug 13, 2025

Citius Pharmaceuticals shares fall 3.85% intraday after reporting fiscal third quarter results and raising $12.5 million in financings. - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

Citius Oncology Inc. stock chart pattern explained2025 Breakouts & Breakdowns & Smart Allocation Stock Tips - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Identifying reversal signals in Citius Oncology Inc.Earnings Trend Report & Real-Time Market Sentiment Alerts - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Citius Oncology Beats Fiscal Q3 EPS - AOL.com

Aug 13, 2025
pulisher
Aug 12, 2025

Citius Oncology Beats Q3 EPS Estimates with $0 Revenue - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update - The Malaysian Reserve

Aug 12, 2025
pulisher
Aug 12, 2025

Citius Pharmaceuticals reports Q3 EPS (8c) vs.(7c) last year - TipRanks

Aug 12, 2025
pulisher
Aug 12, 2025

LYMPHIR Launch Readiness vs. Cash Shortfall: Citius Oncology Raises $9M - Stock Titan

Aug 12, 2025
pulisher
Aug 12, 2025

Risk adjusted return profile for Citius Oncology Inc. analyzedPrice Forecast Based on AI Analysis - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

Citius Oncology Announces Pricing of $9.0 Million Public Offering - ADVFN Brasil

Aug 11, 2025
pulisher
Aug 11, 2025

Smart tools for monitoring Citius Oncology Inc.’s price actionHigh Yield Signals with Entry Timing - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Citius Oncology Inc. stock trend outlook and recovery pathStrategy Chart for Real-Time Trade Flow - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Chart overlay techniques for tracking Citius Oncology Inc.Free Capital Protection Trading Strategies - Newser

Aug 10, 2025
pulisher
Aug 09, 2025

Is Now a Good Time to Reenter Citius Oncology Inc.Watchlist for Low Risk High Return Stocks Updated - beatles.ru

Aug 09, 2025
pulisher
Aug 09, 2025

Citius Oncology IncAnticipates Commercial Launch of Lymphir in 2025 - 富途牛牛

Aug 09, 2025
pulisher
Aug 06, 2025

Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators - Benzinga

Aug 06, 2025
pulisher
Aug 04, 2025

What analysts say about Citius Oncology Inc. stockMaximize gains with proven stock analysis - Jammu Links News

Aug 04, 2025
pulisher
Aug 03, 2025

What institutional investors are buying Citius Oncology Inc. stockInvest smarter with expert stock recommendations - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the risk reward ratio of investing in Citius Oncology Inc. stockUnlock exclusive trading strategies for gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is Citius Oncology Inc. stock compared to the marketGet professional advice for portfolio optimization - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Does Citius Oncology Inc. stock perform well during market downturnsUnlock real-time stock alerts for quick profits - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How strong is Citius Oncology Inc. company’s balance sheetSkyrocketing returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the latest earnings results for Citius Oncology Inc.Free Stock Market Trend Analysis - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Why is Citius Oncology Inc. stock attracting strong analyst attentionAchieve breakthrough investment performance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is Citius Oncology Inc. company’s growth strategyBuild a portfolio for long-term financial success - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell Citius Oncology Inc. stock in 2025Capitalize on market trends early - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What drives Citius Oncology Inc. stock priceGet timely market insights for better trades - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are analysts’ price targets for Citius Oncology Inc. in the next 12 monthsFree Daily Trading Room Entry - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Citius Oncology Inc. compare to its industry peersBreakthrough stock performance - Jammu Links News

Aug 03, 2025
pulisher
Jul 31, 2025

How does Citius Oncology Inc. generate profit in a changing economyPost Market Target Finder To Watch Now - Jammu Links News

Jul 31, 2025
pulisher
Jul 30, 2025

What makes Citius Oncology Inc. stock attractive to long term investorsPortfolio Diversification Stock Ideas From Experts - metal.it

Jul 30, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 19:38:23 - metal.it

Jul 29, 2025

Finanzdaten der Citius Oncology Inc-Aktie (CTOR)

Es liegen keine Finanzdaten für Citius Oncology Inc (CTOR) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$29.14
price down icon 2.02%
$17.76
price down icon 0.77%
drug_manufacturers_specialty_generic RDY
$14.45
price down icon 0.49%
$10.54
price down icon 1.05%
$134.25
price down icon 0.85%
$307.10
price down icon 1.73%
Kapitalisierung:     |  Volumen (24h):